STERIS plc

STE · NYSE · USD

Analyst consensus

Buy14 analysts

Bearish · 0 · Hold · 2 · Bullish · 12

Earnings history

	EPS	Estimate
Q2 2025	$2.14	$2.12	Beat
Q3 2025	$2.32	$2.33	Miss
Q4 2025	$2.74	$2.60	Beat
Q1 2026	$2.34	$2.26	Beat
Q2 2026	$2.47	$2.35	Beat
Q3 2026	$2.53	$2.53	Match
Q4 2026	$2.83	$2.85	Miss
Q1 2027	$2.59	$2.49	Beat

Peers

Company overview

IPO dateJun 1, 1992

CEODaniel A. Carestio

Employees17,937

SectorHealthcare

IndustryMedical - Specialties

CountryUS

ExchangeNew York Stock Exchange

Websitewww.steris.com

STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. The company operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. It offers a range of products including cleaning chemistries, sterility assurance products, automated endoscope reprocessing systems, surgical tables, lights, and connectivity solutions. It also provides services such as equipment maintenance, instrument repair, and contract sterilization for medical device and pharmaceutical manufacturers.

Athenic provides research and information tools for educational purposes only and is not a registered investment adviser or broker-dealer. Nothing on this page is investment advice or a recommendation to buy or sell any security. Market data may be delayed. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal.